Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis

• Main Authors: Matthias Augustin (Author), Andrea Bauer (Author), Konstantin Ertner (Author), Ralph von Kiedrowski (Author), Florian Schenck (Author), Jutta Ramaker-Brunke (Author), Sophie Möller (Author), Anja Fait (Author), Mike Bastian (Author), Diamant Thaçi (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Dupilumab has significantly improved the signs, symptoms and quality of life (QoL) of patients with moderate-to-severe atopic dermatitis (AD) in randomised, controlled clinical trials. However, there is a need to assess the effectiveness and safety of dupilumab in real-world cl...